Paper11951146
Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial.
Müller-Vahl KR and 6 others. Pharmacopsychiatry, 2002. Cited by 160 papers, by iCite.
Cite this record
ConductScience Library. Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial. Papers, record 11951146. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11951146
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dronabinol | Major topic |
| Tourette Syndrome | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Cross-Over Studies | |
| Double-Blind Method | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Pilot Projects | |
| Psychiatric Status Rating Scales | |
| Tics | |
| Treatment Outcome |
Source PubMed
Cited by76
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 160 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42466383 | Psychiatric effects of cannabidiol, cannabinol, and tetrahydrocannabinol: A narrative review of clinical evidence and risk profiles. | PCN Rep | 2026 | https://conductscience.org/library/papers/42466383 | PubMed |
| 41556111 | Investigating medical cannabis for adolescents with Tourette syndrome: tread carefully. | BJPsych Open | 2026 | https://conductscience.org/library/papers/41556111 | PubMed |
| 41113190 | Long-term use of cannabis-based medicines in two children with Tourette syndrome: a case report. | Front Psychiatry | 2025 | https://conductscience.org/library/papers/41113190 | PubMed |
| 40901261 | Case Report: Effect of medicinal cannabis on fitness to drive in a patient with Tourette Syndrome and ADHD. | Front Psychiatry | 2025 | https://conductscience.org/library/papers/40901261 | PubMed |
| 40162008 | Exploring acupuncture as a therapeutic approach for tic disorders: a review of current understanding and potential benefits. | Front Neurol | 2025 | https://conductscience.org/library/papers/40162008 | PubMed |
| 39739176 | The Use of Cannabis-Based Medicine in Selected Neurological Disorders. | Curr Top Behav Neurosci | 2026 | https://conductscience.org/library/papers/39739176 | PubMed |
| 39558767 | Pain in Tourette Syndrome: A Comprehensive Review. | J Child Adolesc Psychopharmacol | 2025 | https://conductscience.org/library/papers/39558767 | PubMed |
| 39134752 | [Cannabis use and cannabis use disorders]. | Nervenarzt | 2024 | https://conductscience.org/library/papers/39134752 | PubMed |
| 38985199 | Efficacy of cannabis-based medicine in the treatment of Tourette syndrome: a systematic review and meta-analysis. | Eur J Clin Pharmacol | 2024 | https://conductscience.org/library/papers/38985199 | PubMed |
| 38891938 | The Use of Compounds Derived from Cannabis sativa in the Treatment of Epilepsy, Painful Conditions, and Neuropsychiatric and Neurodegenerative Disorders. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38891938 | PubMed |
| 38428836 | Cannabinoids in the Treatment of Selected Mental Illnesses: Practical Approach and Overview of the Literature. | Pharmacopsychiatry | 2024 | https://conductscience.org/library/papers/38428836 | PubMed |
| 38015317 | Therapeutic use of medical Cannabis in neurological diseases: a clinical update. | J Neural Transm (Vienna) | 2024 | https://conductscience.org/library/papers/38015317 | PubMed |
| 37962703 | Pharmacological treatment of Tourette's syndrome: from the past to the future. | Neurol Sci | 2024 | https://conductscience.org/library/papers/37962703 | PubMed |
| 37906390 | Exploring the therapeutic potential of natural compounds modulating the endocannabinoid system in various diseases and disorders: review. | Pharmacol Rep | 2023 | https://conductscience.org/library/papers/37906390 | PubMed |
| 37332633 | Premonitory Urge and Tic Severity, Comorbidities, and Quality of Life in Chronic Tic Disorders. | Mov Disord Clin Pract | 2023 | https://conductscience.org/library/papers/37332633 | PubMed |
| 37107712 | Medicinal Cannabis for Paediatric Developmental, Behavioural and Mental Health Disorders. | Int J Environ Res Public Health | 2023 | https://conductscience.org/library/papers/37107712 | PubMed |
| 36864363 | Efficacy of cannabinoids in neurodevelopmental and neuropsychiatric disorders among children and adolescents: a systematic review. | Eur Child Adolesc Psychiatry | 2024 | https://conductscience.org/library/papers/36864363 | PubMed |
| 36628122 | Historical Pathways for Opioid Addiction, Withdrawal with Traditional and Alternative Treatment Options with Ketamine, Cannabinoids, and Noribogaine: A Narrative Review. | Health Psychol Res | 2022 | https://conductscience.org/library/papers/36628122 | PubMed |
| 36342913 | Use of Medical Cannabis in Patients with Gilles de la Tourette's Syndrome in a Real-World Setting. | Cannabis Cannabinoid Res | 2024 | https://conductscience.org/library/papers/36342913 | PubMed |
| 36169325 | The role of cannabinoids in neurodevelopmental disorders of children and adolescents. | Rev Neurol | 2022 | https://conductscience.org/library/papers/36169325 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11951146
GET https://conductscience.org/api/papers/v1/11951146/cited_by?page=2